Conversely, the EGFR-TKI erlotinib induces autophagy possibly through EGFR/beclin-1 complex disruption and promotes the initiation of autophagy in EGFR-mutated NSCLC cells (HCC827) [110]. The gene discussed is BECN1; the disease is non-small cell lung carcinoma.